inhaled insulin
South Korea jails executives for their role in Samsung Biologics fraud
December 10, 2019Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea
Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …
Afrezza could breathe new life into inhaled insulin market
August 15, 2011Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news
New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …
Pfizer abandons Exubera
October 19, 2007Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …
Exubera approval limited to needle-phobic patients
January 26, 2007Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin
Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …
Pfizer to go it alone with Exubera
January 16, 2006Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
